Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review

QR Code

Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review

Yujing Shi,1 Xiaolin Ge,2 Mengyang Ju,3 Yumeng Zhang,4 Xiaoke Di,2 Liang Liang1 1Jurong People’s Hospital, Zhenjiang, 212400, People’s Republic of China; 2Jiangsu Provincial People’s Hospital, Nanjing, 212000, People’s Republic of China; 3Department of Radiation Oncology, Osaka University Graduate S...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shi Y, Ge X, Ju M, Zhang Y, Di X, Liang L
Format:	article
Language:	EN
Published:	Dove Medical Press 2021
Subjects:	esophageal squamous cell carcinoma circulating tumor cells diagnostic prognostic Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Online Access:	https://doaj.org/article/aa1b9caca6b6428d81d1518561b4d091
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
by: Jiannan Yao, et al.
Published: (2021)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021)

New Trend of Surgery in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
by: Tatcha Rerkrak, et al.
Published: (2021)

Relation Between Tumor Budding and Endoscopic Classification, Degree of Malignancy in T1 Stage Esophageal Squamous Cell Carcinoma
by: WANG Kang, et al.
Published: (2021)

Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma
by: Wang J, et al.
Published: (2021)

A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
by: Shi X, et al.
Published: (2021)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
by: Pei-Hung Chang, et al.
Published: (2021)

Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta‐analysis
by: Chengcheng Guo, et al.
Published: (2021)

IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
by: Alena Gribko, et al.
Published: (2021)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
by: Hongfu Cai, et al.
Published: (2021)

Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma
by: Li Mengyan, et al.
Published: (2021)

Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma
by: Ke Shi, et al.
Published: (2021)

Correlation of Human Papillomavirus Infection with Esophageal Squamous Cell Carcinoma
by: O Emadian, et al.
Published: (2011)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
by: Jerry Polesel, et al.
Published: (2021)

A multi‐omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma
by: Xing Jin, et al.
Published: (2021)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
by: Tian Zeng, et al.
Published: (2021)

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
by: Xinxin Zhu, et al.
Published: (2021)

Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma
by: Wenjian Yao, et al.
Published: (2021)

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
by: Peng Yang, et al.
Published: (2021)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
by: Jason Chia‐Hsun Hsieh, et al.
Published: (2021)

Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database
by: Danlei Song, et al.
Published: (2021)

Acantholytic Squamous Cell Carcinoma
by: Sandy Maganito, et al.
Published: (2021)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
by: Xiayao Diao, et al.
Published: (2021)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
by: Yang Li, et al.
Published: (2021)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
by: Karl Payne, et al.
Published: (2021)

Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
by: Qilin Zhang, et al.
Published: (2021)

Pigmented Squamous Cell Carcinoma: Is the Reported Prevalence Real?
by: Paola Corneli, et al.
Published: (2019)

Comparison of Magnifying Endoscopy with Blue Light Imaging and Narrow Band Imaging for Determining the Invasion Depth of Superficial Esophageal Squamous Cell Carcinoma by the Japanese Esophageal Society’s Intrapapillary Capillary Loop Classification
by: Waku Hatta, et al.
Published: (2021)

Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
by: Gabriella Brancaccio, et al.
Published: (2021)

A methyltransferase‐like 14/miR‐99a‐5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2‐mediated epigenetic modulation in esophageal squamous cell carcinoma
by: Zhenchuan Liu, et al.
Published: (2021)

Circulating Natural Autoantibodies to HER2-Derived Peptides Performed Antitumor Effects on Oral Squamous Cell Carcinoma
by: Xiu Liu, et al.
Published: (2021)

A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
by: Seyed Mohammad Kazem Aghamir, et al.
Published: (2021)

Association between Helicobacter Pylori (H. Pylori) Infection and Esophageal Squamus Cell Carcinoma (ESCC)
by: J Shokry-Shirvany, et al.
Published: (2012)

Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions
by: Zhihao Chen, et al.
Published: (2021)

Development and Validation of Prognostic Models for Oral Squamous Cell Carcinoma: A Systematic Review and Appraisal of the Literature
by: Diana Russo, et al.
Published: (2021)

Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
by: Jialin Qu, et al.
Published: (2021)

Squamous cell carcinoma of the nail unit
by: Michela Starace, et al.
Published: (2018)

Disulfiram Inhibits Epithelial–Mesenchymal Transition Through TGFβ–ERK–Snail Pathway Independently of Smad4 to Decrease Oral Squamous Cell Carcinoma Metastasis [Corrigendum]
by: Bu W, et al.
Published: (2021)

Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma
by: Minami S, et al.
Published: (2016)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
by: Lucrezia Togni, et al.
Published: (2021)